Hepatocellular carcinoma and hepatitis C in the United States.
about
Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infectionGenes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinomaGene profiling, biomarkers and pathways characterizing HCV-related hepatocellular carcinomaHepatitis C virus genotype 3a infection and hepatocellular carcinoma: Pakistan experienceAssociation between hepatitis C and hepatocellular carcinomaTargeted proteomics for biomarker discovery and validation of hepatocellular carcinoma in hepatitis C infected patientsDiagnostic Accuracy of 2D-Shear Wave Elastography for Liver Fibrosis Severity: A Meta-AnalysisComparison of magnetic resonance elastography and diffusion-weighted imaging for staging hepatic fibrosis.Assessment of chronic hepatitis and fibrosis: comparison of MR elastography and diffusion-weighted imagingA brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluation.c-MYC-Making Liver Sick: Role of c-MYC in Hepatic Cell Function, Homeostasis and Disease.TAT-LHRH conjugated low molecular weight chitosan as a gene carrier specific for hepatocellular carcinoma cellsAlkaline phosphatase predicts relapse in chronic hepatitis C patients with end-of-treatment response.A comparison of four fibrosis indexes in chronic HCV: development of new fibrosis-cirrhosis index (FCI)The prevalence of hepatitis C virus infection in Texas: implications for future health careRisk factors, genotype 6 prevalence, and clinical characteristics of chronic hepatitis C in Southeast Asian Americans.Development of hepatitis C virus vaccine using hepatitis B core antigen as immuno-carrier.Liver cirrhosisDendritic cell-mediated, DNA-based vaccination against hepatitis C induces the multi-epitope-specific response of humanized, HLA transgenic mice.Detection and characterization of liver lesions using gadoxetic acid as a tissue-specific contrast agent.Radiologic-pathologic correlation of hepatocellular carcinoma treated with chemoembolizationHepatocellular carcinoma in the world and the middle East.Chemoembolization for hepatocellular carcinoma: comprehensive imaging and survival analysis in a 172-patient cohort.Hepatitis C progressing to hepatocellular carcinoma: the HCV dialysis patient in dilemma.Role of MicroRNAs in Hepatocellular CarcinomaIdentification of hepatitis C virus inhibitors targeting different aspects of infection using a cell-based assayDual induction of caspase 3- and transglutaminase-dependent apoptosis by acyclic retinoid in hepatocellular carcinoma cells.Association of Helicobacter species with hepatitis C cirrhosis with or without hepatocellular carcinomaFirst multicenter study for risk factors for hepatocellular carcinoma development in North Africa.Viral hepatocarcinogenesis.Body mass index is associated with age-at-onset of HCV-infected hepatocellular carcinoma patients.Role of the EASL, RECIST, and WHO response guidelines alone or in combination for hepatocellular carcinoma: radiologic-pathologic correlationIndoleamine 2,3-dioxygenase expression and activity in patients with hepatitis C virus-induced liver cirrhosis.Imaging response in the primary index lesion and clinical outcomes following transarterial locoregional therapy for hepatocellular carcinoma.HCV genotype-specific correlation with serum markers: higher predictability for genotype 4aEvidence for heightened hexokinase II immunoexpression in hepatocyte dysplasia and hepatocellular carcinomaDownregulation of Gadd45beta expression by hepatitis C virus leads to defective cell cycle arrest.Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma.Sustained eradication of hepatitis C virus by low-dose long-term interferon therapy in a renal transplant recipient with dual infection with hepatitis B and C viruses: a case report.Radiographic response to locoregional therapy in hepatocellular carcinoma predicts patient survival times.
P2860
Q27469828-CCC7F2EF-88D6-437E-ADB4-74F2CADB40FCQ27487515-ECA0F719-89B8-4CF1-90D4-1F02545D14E9Q27490242-6F5415A8-62EF-41DE-9C32-B75580C522A1Q27490250-C4ECE354-44CC-49FE-8E7A-AD74858C0D18Q27491295-53A35E46-D5FB-4438-ACC6-0B66C0A7638BQ28085015-E8718D14-D8D0-4E7D-B4D6-1384389313BFQ30378824-CF61F7CA-483B-40C2-A45D-5991726392FFQ30384892-3DBBCF6A-9D73-4C86-B4CD-B62E5AB60030Q30474248-B8BCA759-2F4D-40C7-AA1D-0993231F65F6Q30476922-C431249B-A60A-46E4-BDF9-C8C8CCDC7DB2Q33608524-E95E11D4-0A2B-40FD-8584-C9D5568AEC83Q33769475-2C00AEFA-AD01-4237-AE07-EDF3DD420F4EQ33867357-FA5F250A-3513-42EE-8D14-C1FA0B00FA22Q33877980-A18747F0-716B-4DFB-9087-AA5309329597Q33945047-78F549FB-71D0-4C0D-9E5D-4F1E4C4AC49DQ33977173-4EDC9D4E-22A0-49F2-9387-FC4743810C02Q34001755-5969CEA3-4738-4BDA-A019-F420BC75167FQ34010340-72FF77FD-0356-4C58-8D95-4A8BCBC93B98Q34028154-495D885D-CB82-466C-B054-821F6AD12E9AQ34064365-8B0497DD-9480-4DB8-AA28-9241D749ADB8Q34065098-482C27B3-12A4-4532-B6FC-73B77F16B1C1Q34134967-BDC9E8BF-79EE-4602-AFA2-A871ED90064BQ34168811-F799B243-8736-4A95-AA5B-663B81D5050FQ34207872-CB950BE4-8C29-4554-813F-FCF0BDFD59EEQ34348824-5817A024-8573-4BD7-8189-4B2062FF3D1BQ34403294-493F9126-C649-434D-94BA-8BA0EDC22B46Q34506882-BDEFDEF4-32C2-46A1-BC3F-E8C524723D2DQ34555080-ED97972A-1542-4614-B24D-05D369850CD0Q34560817-38D58E99-903C-4CB8-A22A-25CD5A044E39Q34617749-5AABCBC2-7547-47AF-9FDF-3B6F03C8FADDQ34635064-30EA53F1-BAD6-4FF6-ABCA-893426E223DAQ34982068-2398A872-70EE-40CF-BADD-4D2B8DC38E3EQ35048483-A91A0AC8-67B5-4D64-9DBC-EC298F508D6DQ35051942-155C664E-49DB-45D7-8C61-CAB2770F0576Q35068407-3A4E9B86-69C4-460B-84BE-0E37C6E69F7BQ35068600-B1181CFF-0E52-4B7C-9D44-72C5039D2B24Q35075425-626952E6-67F4-4899-ABA1-D10776EBFA09Q35085486-DE1EAFB9-B7F4-41B8-9BF4-70FC8323FD18Q35122289-C910D2AC-6A79-4B66-A32B-56F52C6110C1Q35154103-04F02C00-4405-4C57-9734-5D239F31A356
P2860
Hepatocellular carcinoma and hepatitis C in the United States.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Hepatocellular carcinoma and hepatitis C in the United States.
@ast
Hepatocellular carcinoma and hepatitis C in the United States.
@en
Hepatocellular carcinoma and hepatitis C in the United States.
@nl
type
label
Hepatocellular carcinoma and hepatitis C in the United States.
@ast
Hepatocellular carcinoma and hepatitis C in the United States.
@en
Hepatocellular carcinoma and hepatitis C in the United States.
@nl
prefLabel
Hepatocellular carcinoma and hepatitis C in the United States.
@ast
Hepatocellular carcinoma and hepatitis C in the United States.
@en
Hepatocellular carcinoma and hepatitis C in the United States.
@nl
P2860
P356
P1433
P1476
Hepatocellular carcinoma and hepatitis C in the United States.
@en
P2093
Hashem B El-Serag
P2860
P304
P356
10.1053/JHEP.2002.36807
P407
P433
P577
2002-11-01T00:00:00Z